Robertson Erin, Naghavi Nader, Wipperman Matthew F, Tuckwell Katie, Effendi Muhammad, Alaj Rinol, Urbanek Jacek, Lederer David, Fredenburgh Laura, Stuart Samuel
Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, UK.
Digit Health. 2024 Sep 11;10:20552076241277174. doi: 10.1177/20552076241277174. eCollection 2024 Jan-Dec.
This review examined literature that has examined mobility in pulmonary arterial hypertension (PAH) using digital technology. Specifically, the review focussed on: (a) digital mobility measurement in PAH; (b) commonly reported mobility outcomes in PAH; (c) PAH specific impact on mobility outcomes; and (d) recommendations concerning protocols for mobility measurement in PAH. PubMed, Scopus, and Medline databases were searched. Two independent reviewers screened articles that described objective measurement of mobility in PAH using digital technology. Twenty-one articles were screened, and 16 articles met the inclusion/exclusion criteria and were reviewed. Current methodologies for mobility measurement in PAH with digital technologies are discussed. In brief, the reviewed evidence demonstrated that there is a lack of standardisation across studies for instrumentation, outcomes, and interpretation in PAH. The validity and reliability of digital approaches were insufficiently reported in all studies. Future research is required to standardise digital mobility measurement and characterise mobility impairments in PAH across clinical and real-world settings. The reviewed evidence suggests that digital mobility outcomes may be useful clinical measures and may be impaired in PAH, but further research is required to accurately and robustly establish findings. Recommendations are provided for future studies that encompass comprehensive reporting, validation, and measurement.
本综述研究了使用数字技术检测肺动脉高压(PAH)患者活动能力的相关文献。具体而言,该综述聚焦于:(a)PAH患者的数字活动能力测量;(b)PAH患者中常见的活动能力结果报告;(c)PAH对活动能力结果的特定影响;以及(d)关于PAH患者活动能力测量方案的建议。检索了PubMed、Scopus和Medline数据库。两名独立评审员筛选了描述使用数字技术客观测量PAH患者活动能力的文章。共筛选出21篇文章,其中16篇符合纳入/排除标准并进行了评审。讨论了目前使用数字技术测量PAH患者活动能力的方法。简而言之,综述证据表明,PAH研究在仪器设备、结果和解释方面缺乏标准化。所有研究中对数字方法的有效性和可靠性报告不足。未来需要开展研究,以规范数字活动能力测量,并在临床和现实环境中描述PAH患者的活动能力损害情况。综述证据表明,数字活动能力结果可能是有用的临床指标,且PAH患者的活动能力可能受损,但需要进一步研究以准确、有力地证实这些发现。为未来研究提供了涵盖全面报告、验证和测量的建议。